Snapshot from Jul 07, 2026 at 01:18 UTC. For live data and tracking: View Live
Entities / Cancer Research UK / Peter Johnson

Cancer Research UK & Peter Johnson

2 shared events · Importance 3 · Last updated Jul 01, 2026

Importance
3
Shared Events
2
Actions
0
Sentiment
0
Live sentiment trends, interaction importance charts, and action volume tracking available on the Ergen Dashboard
Shared Events (2)
35
Tech
NHS Rolls Out Pembrolizumab for Cervical Cancer
Cancer Research UK: Cancer Research UK provided statistics on cervical cancer and commented on the positive impact of pembrolizumab's availability.
Peter Johnson: Peter Johnson as the United Kingdom — National Health Service National Clinical Director for Cancer, expressed positive views on the new treatment, highlighting its significance for patients.
Jun 25, 2026 · 6 articles
0
Tech
NHS Rolls Out One-Minute Cancer Jab
May 03, 2026 · 8 articles
NEWSDESK
Explore this relationship live

Track how Cancer Research UK and Peter Johnson interact across events, view sentiment trends, and discover connected entities.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.